Materiały źródłowe

• #1 Myelodysplastic syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Myelodysplastic_syndrome

  A myelodysplastic syndrome (MDS) is one of a group of cancers in which blood cells in the bone marrow do not mature, and as a result, do not develop into healthy blood cells. Early on, no symptoms typically are seen. Later, symptoms may include fatigue, shortness of breath, bleeding disorders, anemia, or frequent infections. Some types may develop into acute myeloid leukemia. […] Treatments may include supportive care, drug therapy, and hematopoietic stem cell transplantation. Supportive care may include blood transfusions, medications to increase the making of red blood cells, and antibiotics. Drug therapy may include the medications lenalidomide, antithymocyte globulin, and azacitidine. Some people can be cured by chemotherapy followed by a stem-cell transplant from a donor. […] The goals of therapy are to control symptoms, improve quality of life, improve overall survival, and decrease progression to AML. The IPSS scoring system can help guide therapy for patients with MDS. In those with low risk MDS (designated by an IPSS score less than 3.5), no disease specific treatment has been found to be helpful and treatment is focused on supportive care by maintaining blood counts. Erythrostimulating agents such as darbepoetin alfa or erythropoietin may be used to raise the red blood cell count.

• #1 Myelodysplastic neoplasms (MDS) – Leukaemia Foundation

  https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/myelodysplastic-syndromes/

  Myelodysplastic neoplasms (MDS) are a group of blood cancers which all affect the production of normal blood cells in the bone marrow. MDS occurs as a result of a mutation (or change) in one or more of the genes that control blood cell development. This change or changes results in the abnormal growth of blood stem cells. […] In MDS, abnormal bone marrow stem cells (called blast cells) produce increased numbers of immature blood cells. These cells do not grow properly and often die prematurely. This results in lower numbers of: mature red blood cells, white blood cells, platelets. […] While MDS can occur at any age, most cases develop over the age of 60. MDS can occur very occasionally in children. […] In most cases, there is no specific cause of MDS. MDS is either: primary, or de novo – where there is no known cause; secondary, or treatment-related – where a person diagnosed with MDS has had prior chemotherapy and/or radiation therapy. Only 5-10% of people with MDS have treatment-related disease.

• #1 Myelodysplastic neoplasms (MDS) – Leukaemia Foundation

  https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/myelodysplastic-syndromes/

  Many people in the early stages of MDS have no symptoms at all and it is picked up accidentally during a routine blood test. In other cases, people go to their doctor because they are experiencing some troubling symptoms. […] The most common symptoms of MDS: Anaemia, caused by a lack of red cells: persistent tiredness and fatigue, weakness, shortness of breath with minimal exercise, looking pale. […] Your treatment team will discuss your type of MDS and your treatment options. […] Your haematologist will recommend treatment based on: the type of MDS you have, your age, your general health, your prognosis, your wishes. […] Supportive care controls symptoms of MDS and side effects. Supportive care aims to improve quality of life. It is frequently used for older people or those with other health problems.

• #1 Myelodysplastic Syndromes (MDS) | UH Seidman Cancer Center | University Hospitals | University Hospitals

  https://www.uhhospitals.org/services/cancer-services/hematologic-malignancy/leukemia/myelodysplastic-syndromes

  Medication therapy for myelodysplastic syndromes may include some combination of the following: […] A bone marrow transplant, also known as a stem cell transplant, is the only treatment option that can potentially cure MDSs. […] Because a bone marrow transplant carries a high risk of complications, this procedure is reserved for patients deemed healthy enough to endure it. […] Some people with a MDS live for years and require little or no treatment. […] For others, their MDS is more aggressive and may develop into acute myeloid leukemia (AML), which is an aggressive, life-threatening cancer that requires more urgent treatment.

• #1 Treatment for Myelodysplastic Syndrome (MDS) | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/cancer-care/types/myelodysplastic-syndrome/treatment

  If you have been diagnosed with myelodysplastic syndrome (MDS), Memorial Sloan Kettering doctors will devise a course of treatment specific to you. We will take a number of factors into consideration, including: […] Supportive care is the cornerstone of all MDS treatments. Its goal is to help alleviate or prevent symptoms from low blood counts. […] Even if you are receiving chemotherapy for MDS or in preparation for a stem cell transplant, you will also receive supportive care. […] For people with MDS who are not eligible for a stem cell transplant, Memorial Sloan Kettering offers the following treatment options: […] Lenalidomide has to be used very carefully. Even if it improves the hemoglobin level and the anemia gets better, it will actually decrease levels of neutrophils. This type of white blood cell is the body’s first line of defense against most infections. Lenalidomide will also decrease the platelet count. These lowered counts increase the risk of bleeding and infection.

• #1 Myelodysplastic Syndrome (MDS) Treatment & Management: Approach Considerations, Supportive Care, Pharmacologic Therapy

  https://emedicine.medscape.com/article/207347-treatment

  Supportive care includes transfusion of red blood cells (RBCs) or platelets. The goal is to replace cells that are prematurely undergoing apoptosis in the patient’s bone marrow. […] Patients with low-risk or intermediate-1 risk MDS typically have long-term survival and may receive multiple RBC transfusions. These patients may develop transfusion-induced iron overload and can incur significant damage of the liver, heart, pancreas, and other tissues. […] Current guidelines recommend starting iron chelation therapy in those patients who have received 20-25 units of packed RBCs or who have a serum ferritin level of 1000 g/L. […] Hematopoietic growth factors can stimulate bone marrow cell production and decrease excess bone marrow cell apoptosis. […] Cytotoxic chemotherapy is used in patients with MDS with increasing myeloblasts and those who have progressed to acute leukemia.

• #1 https://www.lls.org/myelodysplastic-syndromes/treatment/supportive-care

  https://www.lls.org/myelodysplastic-syndromes/treatment/supportive-care

  Treatment given to relieve the symptoms of a disease and the treatments side effects is known as supportive care. The goal of supportive care is to improve the patients quality of life and to relieve discomfort as much as possible. Supportive care is an important part of MDS treatment. […] For patients who need frequent red blood cell transfusions, it is recommended that doctors monitor serum ferritin (iron) levels and check often for signs of organ damage. […] A low number of white blood cells can increase the risk of infection. In some cases, infection may be frequent or severe. Your treatment team will pay close attention to any infection or unexplained fever. If a bacterial infection is identified or suspected, antibiotics may be needed. Antiviral drugs may be used to treat certain viral infections.

• #1 Myelodysplastic Syndromes (MDS): Causes, Symptoms, Treatment

  https://www.webmd.com/cancer/lymphoma/myelodysplastic-syndrome-causes-symptoms-treatment

  Here are some things to improve your health and well-being while living with MDS: […] To reduce your risk of infection, wash your hands frequently, cook your food well, avoid eating raw foods, and avoid being in close contact with people who are ill. […] Quit smoking or tobacco. […] Be as active as possible, eat healthy foods, and take your sleep seriously. […] Find and join a support group to meet with and learn from others who can relate to your experience with MDS. […] To relax your body and clear your mind, practice mindfulness and meditation practices like deep breathing, yoga, and journaling. […] Get professional mental health help from a therapist or counselor if living with MDS feels too overwhelming.

• #1 Myelodysplastic Syndromes Treatment – NCI

  https://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq

  Erythropoiesis-stimulating agents (ESAs) may be given to increase the number of mature red blood cells made by the body and to lessen the effects of anemia. […] Antibiotics may be given to fight infection. […] Patients with myelodysplastic syndrome associated with an isolated del(5q) chromosome abnormality who need frequent red blood cell transfusions may be treated with lenalidomide. […] Azacitidine and decitabine are used to treat myelodysplastic syndromes by killing cells that are dividing rapidly. […] Chemotherapy is given to kill cancer cells. Healthy cells, including blood-forming cells, are also destroyed by the cancer treatment. Stem cell transplant is a treatment to replace the blood-forming cells. […] Treatment for myelodysplastic syndromes may cause side effects. […] For some patients, taking part in a clinical trial may be the best treatment choice. […] There is no standard treatment for refractory or relapsed myelodysplastic syndromes.

• #1 Patient education: Myelodysplastic syndromes (MDS) in adults (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/myelodysplastic-syndromes-mds-in-adults-beyond-the-basics/print

  Transfusion of red blood cells or platelets can be given to relieve symptoms or when these blood counts become dangerously low. […] Hematopoietic growth factors promote the growth and development of blood cells and may reduce the need for blood transfusions. However, many people with MDS do not respond adequately to hematopoietic growth factors because of the bone marrow’s defective production of blood cells, and the use of growth factors typically does not prolong survival. […] Vaccines help prevent infections and are especially important for people with MDS who have an increased risk of infections. However, not all vaccines are safe and appropriate for people with MDS, and they may not be as effective in people with MDS. […] High-intensity chemotherapy is not generally recommended for people >75 years old or for people with poor medical fitness or overall function. For these people, the expected benefit (prolonged survival) may not be worth the anticipated discomfort, hospitalization, or risk of death from the effects of chemotherapy. […] Stem cell transplantation is the treatment for MDS most associated with long-term survival, although long-term survivors can have complications such as „graft-versus-host disease” (GVHD). […] There is great interest in clinical trials for improving treatment of MDS. […] false

• #1 Myelodysplastic Syndrome (MDS) Treatment & Management: Approach Considerations, Supportive Care, Pharmacologic Therapy

  https://emedicine.medscape.com/article/207347-treatment

  The standard care for patients with myelodysplastic syndrome (MDS) and decreased blood counts is constantly changing. Supportive therapy, including transfusions of the cells that are deficient (ie, red blood cells [RBCs], platelets), and treatment of infections are the main components of care. […] Patients with MDS should be under the care of a hematologist. Because most treatments for MDS are not standard and are considered experimental, referral to a tertiary care center with bone marrow transplantation capabilities is often necessary. […] Although treatment of symptoms improves quality of life in MDS, these measures are temporary. More long-term measures are necessary to stimulate the patient’s bone marrow production of mature blood cells. Practitioners are encouraged to refer patients for participation in clinical trials at academic centers and the MDS Centers of Excellence.

• #1 Patient education: Myelodysplastic syndromes (MDS) in adults (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/myelodysplastic-syndromes-mds-in-adults-beyond-the-basics/print

  The prognosis of MDS is variable. Some people with MDS live for years and require little or no treatment. For others, MDS is more aggressive and may evolve into acute myeloid leukemia (AML), a disease with a poor prognosis that requires more urgent treatment. […] Most people with MDS seek care due to symptoms of anemia, such as fatigue, weakness, shortness of breath, chest pain, or dizziness. Less commonly, MDS is diagnosed as a result of an infection, easy bruising, or unusual bleeding. Symptoms such as fever and weight loss are uncommon early in the disease. […] Management of MDS is influenced principally by a person’s risk category (based on the prognostic score). […] For people without symptoms and with lower-risk MDS, management may simply involve close monitoring for disease progression. However, people with symptoms related to MDS, those who require regular blood or platelet transfusions, and those with higher-risk prognostic scores benefit from treatment.

• #1 General Approach to Treatment of Myelodysplastic Syndromes | American Cancer Society

  https://www.cancer.org/cancer/types/myelodysplastic-syndrome/treating/general-approach.html

  Lower-risk MDS is less likely to progress to acute myeloid leukemia (AML) or to cause other serious health problems. But its important to know that each persons outlook is unique. […] Most doctors favor this approach, because its not clear that treating lower-risk MDS in people without symptoms right away helps them live any longer, but it can still cause side effects. […] There is no single best treatment for all people with lower-risk MDS who need to be treated. Treatment is tailored to each persons situation, based on their blood counts and symptoms, as well as other factors. […] People with higher-risk MDS generally need treatment right away, as their MDS is more likely to progress and cause serious problems. […] Regardless of which approach is used, people can also get supportive therapies to help prevent or relieve symptoms from the MDS. Supportive care is important no matter what other treatments a person is getting.

• #1 Patient education: Myelodysplastic syndromes (MDS) in adults (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/myelodysplastic-syndromes-mds-in-adults-beyond-the-basics/print

  Several treatments for MDS can control symptoms, reduce or eliminate the need for blood or platelet transfusions, reduce the risk of complications, and improve the quality of life, and may prolong survival. Treatment choices are influenced by age, overall ability to perform daily tasks, and disease characteristics. […] Supportive care is an important part of the management of all people with MDS. This includes transfusions for low blood cell counts, antibiotics for infection, and certain immunizations. […] People with lower-risk MDS are generally treated with low-intensity therapy or supportive care alone. […] Treatment of people with higher-risk MDS may vary according to age, overall health, and personal preference. […] Supportive care treats MDS-related problems such as infection or anemia as they arise, rather than trying to cure the underlying disease. Supportive care can improve quality of life and may prolong survival for all people with MDS.

• #1 Patient education: Myelodysplastic syndromes (MDS) in adults (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/myelodysplastic-syndromes-mds-in-adults-beyond-the-basics

  Supportive care treats MDS-related problems such as infection or anemia as they arise, rather than trying to cure the underlying disease. Supportive care can improve quality of life and may prolong survival for all people with MDS. […] Transfusion of red blood cells or platelets can be given to relieve symptoms or when these blood counts become dangerously low. […] Hematopoietic growth factors promote the growth and development of blood cells and may reduce the need for blood transfusions. […] Low-intensity chemotherapy — Certain classes of drugs, or low doses of drugs from other classes, may be suggested for people with lower-risk MDS, or for people with higher-risk MDS who cannot tolerate high-intensity treatments. […] High-intensity chemotherapy — People with higher-risk MDS may be treated with low-intensity chemotherapy drugs azacitidine, decitabine, or decitabine/cedazuridine, or with chemotherapy similar to that used for treating acute myeloid leukemia (AML).

• #1 Myelodysplastic syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Myelodysplastic_syndrome

  For those with high risk MDS (characterized by an IPSS score greater than 3.5), the hypomethylating agent azacitidine showed increased survival compared to standard care (supportive care, cytarabine or chemotherapy) and is considered the standard of care. Azacitidine had increased survival (24 months vs 15 months) and higher rates of partial or complete therapeutic response (29% vs 12%) as compared to conventional care.

• #1 Myelodysplastic Syndromes Treatment (PDQ®) – NCI

  https://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq

  Allogeneic HSCT is the only potentially curative treatment for MDS. Retrospective data suggest cure rates in selected patients ranging from 30% to 60%; outcomes varied with IPSS score at time of transplant, with inferior survival in patients with higher IPSS scores. […] Although HSCT represents the only treatment modality with curative potential, the relatively high morbidity and mortality of this approach limits its use.

• #1 Myelodysplastic syndromes: a review for nurses – PubMed

  https://pubmed.ncbi.nlm.nih.gov/2003103/

  The Myelodysplastic Syndromes (MDS) are a group of hematologic disorders that resemble hematologic malignancies but are often treated much differently. These syndromes result from a clonal disorder of certain stem cells in the bone marrow. Treatment can range from simple supportive care to new and innovative approaches such as immunotherapy. In general, treatment is dictated by the severity of the presenting disease. Oncology nurses, because of their familiarity with the manifestations of cancer, are particularly qualified to intervene for the patient and family experiencing MDS. Nursing interventions, based on a firm understanding of the underlying disease, include patients and family education. In addition, emotional support and symptom management are important nursing roles.

• #1 Myelodysplastic syndromes: update and nursing considerations – World Continuing Education Alliance

  https://wcealms.com/product/myelodysplastic-syndromes-update-and-nursing-considerations/

  This module provides nurses with an update on diagnosis, management and care of patients with myelodysplastic syndromes (MDS), a complex group of disorders of the bone marrow. […] Understanding the effect of a diagnosis of MDS on patients quality of life is an important part of the nursing role and includes consideration of physical, mental, emotional and social wellbeing. […] Many treatment options are available and nurses can educate patients on recognising and managing side effects. […] While there have been promising developments in management, nurses should ensure that patients and their families have a realistic understanding of MDS and ensure that they are aware that treatments other than haematopoietic stem cell transplantation are non-curative.

• #1 Nursing Education Modules on MDS Disease Management and Patient Education | Aplastic Anemia and MDS International Foundation (AAMDSIF)

  https://www.aamds.org/nursing-education-modules-mds-disease-management-and-patient-education

  This program reviews the role of the nurse in educating patients and caregivers about myelodysplastic syndromes (MDS), including: […] Nursing interventions that may improve QOL for MDS patients. […] This program reviews the ways nurses can help patients adjust to living well with myelodysplastic syndromes (MDS), including: […] Strategies to help MDS patients with physical and mental aspects of disease.

• #1 Case Presentation: Myelodysplastic Syndromes

  https://www.oncnursingnews.com/view/case-presentation-myelodysplastic-syndromes

  There are several treatment choices available for patients diagnosed with MDS. […] The treatments include growth factors such as Procrit (epoetin alfa) and Neupogen (filgrastim). […] Hypomethylating agents, such as 5-azacytidine and decitabine, are often used as low-intensity therapies. […] Lenalidomide (Revlimid) is FDA-approved for patients with MDS containing a 5q- abnormality. […] It is important as a nurse practitioner to review the side effects with both the patient and caregivers if present at each office visit. […] Side effects related to taking lenalidomide include thrombocytopenia, serious birth defects, neutropenia, blood clots, skin reactions including rashes, and tumor lysis syndrome. […] The patient was prescribed 10 mg of lenalidomide daily. […] The patient came to the office weekly for 8 weeks, experiencing only thrombocytopenia, which eventually resolved, with the remaining blood counts showing normal levels.

• #1 A Primary Care Approach to Myelodysplastic Syndromes

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4040428/

  PCPs are actively involved in care of patients with cancer, particularly in an era of increasing number of cancer patients and a shortage of oncologists. […] In the face of limited resources, PCP can improve access and quality of care in patients with MDS. […] Patients with lower-risk MDS may follow up primarily with their PCP for several years once the initial diagnosis and treatment plan has been developed, but it is important that patients with higher-risk MDS are referred to a hematologist/oncologist, due to the higher-risk of AML transformation or mortality from complications of cytopenias within 1.5 years of diagnosis. […] This communication is critical as the patient themselves will not likely know who should be responsible for what care and this can lead to confusion and frustration for the patient.

• #1 Myelodysplastic Syndromes (MDS) Care | Rush

  https://www.rush.edu/services/myelodysplastic-syndromes-mds-care

  Rush has myelodysplastic syndromes (MDS) myeloproliferative neoplasms providers in Chicago and Lisle. […] You may receive care through the MDS Comprehensive Clinic at Rush, where a team of specialists including hematologists, pathologists, bone marrow transplantation specialists and research staff gathers to review your condition and create a treatment plan that meets your needs. […] At Rush, your care goes beyond medications and procedures. Youll also have access to supportive oncology services, which can include nutrition counseling, complementary therapies (e.g., acupuncture, massage), palliative care to help manage symptoms and side effects, psychosocial oncology, financial counseling, transportation assistance and more. […] Waterford Place at Rush Copley Medical Center offers you and your loved ones support before, during and after a cancer diagnosis, with all services free of charge or available to anyone diagnosed with cancer. Waterford Place offers education, support groups, stress reduction programs, nutritional counseling, yoga and a salon and spa that provides massages and facials, as well as the largest wig boutique in the Aurora/Fox Valley area. […] Researchers at Rush are investigating new blood disorders and hematologic cancer treatments.

• #1 Myelodysplastic Syndrome (MDS): Symptoms, Diagnosis & Treatment

  https://my.clevelandclinic.org/health/diseases/6192-myelodysplastic-syndrome-myelodysplasia

  People with myelodysplasia may benefit from palliative care. This care helps people manage MDS symptoms and treatment side effects. Just as important, it may help people manage the emotional impact of living with a chronic disease. […] The only cure for MDS is a successful stem cell transplant. Unfortunately, not everyone can have this treatment. Ask your healthcare provider if a transplant is a choice you should consider. […] Myelodysplastic syndrome can cause conditions like anemia, bleeding issues and infections. You should go to the emergency room any time you: Develop a fever thats 100.4 degrees Fahrenheit (38.3 degrees Celsius) or higher. A fever may be a sign you have an infection. You have bleeding that you cant control. […] If you have myelodysplastic syndrome (MDS), you have a form of cancer thats a chronic illness. No illness is easy, but having a chronic illness means also managing the emotional impact of an illness that wont go away. But living with MDS doesnt mean living without hope. Some treatments may slow down MDS. You may be a candidate for a clinical trial evaluating new ways to treat myelodysplastic syndrome. And there are things you can do to help yourself. Ask your healthcare provider about lifestyle changes, like eating well and getting exercise, which can help you be as healthy as possible.

• #1 How Can Palliative Care Help MDS Patients? – HealthTree for Myelodysplastic Syndromes

  https://healthtree.org/mds/community/articles/asco-24-how-can-palliative-care-help-mds-patients

  Dr. Areej El-Jawahri from Massachusetts General Hospital shared findings at the ASCO 2024 conference in June about how palliative care can improve high-risk MDS patients quality of life and better prepare them for potential end-of-life care plans. […] High-risk MDS patients who receive non-intensive chemotherapy often report low quality of life and dont discuss their end-of-life care preferences with their doctor. […] In conclusion, adding a palliative care professional to the healthcare team of high-risk MDS patients on non-intensive chemotherapy improved their quality of life and ability to have timely discussions about end-of-life care preferences. […] We invite you to consider adding a palliative care provider to your healthcare team as soon as possible to gain these benefits.

• #1 What Are Myelodysplastic Syndromes (MDS)?

  https://www.webmd.com/cancer/lymphoma/what-are-myelodysplastic-syndromes-mds

  If you have MDS, it is very important to get the support you need. […] If you are a caregiver, you have a very important role in the life of your loved one who has MDS. Among the many things you can do: Provide support and encouragement. Talk to their medical team to clarify questions. Give medications. Help manage symptoms and side effects. Coordinate doctor appointments. Transport your loved one to and from appointments. Assist with meals. Help around the house. Handle insurance and billing issues.

• #1 Centers of Excellence | MDS Foundation

  https://www.mds-foundation.org/community/centers-of-excellence/

  We believe that access to top-tier care is crucial for individuals living with MDS. That’s why we’ve curated a list of Centers of Excellence dedicated to providing exceptional care and support for MDS patients. […] Centers of Excellence are institutions recognized for their expertise, innovative treatments, and commitment to improving outcomes for MDS patients. […] Provide a second opinion by an MDS expert physician who is up to date on the latest treatments […] Equip you with the most updated diagnostic tools […] Explore our network of Centers of Excellence to discover top-tier institutions dedicated to MDS care and research.

• #1 Myelodysplastic Syndromes (MDS) Care | UC San Diego Health

  https://health.ucsd.edu/care/cancer/cancers-we-treat/leukemia-lymphoma/mds/

  Moores Cancer Center is an MDS Center of Excellence, designated by the Myelodysplastic Syndromes Foundation. […] Patients at an MDS Center of Excellence receive the highest level of care throughout their cancer journey, including: […] Experienced hematopathologists to ensure you receive an accurate diagnosis […] Physicians dedicated to caring for patients with MDS and their families […] State-of-the-art genetic testing to personalize treatment options […] Opportunities to participate in therapeutic clinical trials and MDS research programs […] Access to advanced stem cell transplantation techniques […] A warm and knowledgeable MDS care team. […] MDS can be difficult to diagnose and an accurate diagnosis is crucial for effective treatment. A bone marrow aspirate and biopsy are typically needed to diagnose your condition.

• #1 Myelodysplastic Syndrome | Fred Hutchinson Cancer Center

  https://www.fredhutch.org/en/diseases/myelodysplastic-syndrome.html

  Our physicians and researchers are always asking how we can make MDS treatments more effective and reduce side effects as much as possible. This is why we do clinical trials (also called clinical studies). Through these studies, we are able to offer you therapies that arent offered everywhere. A therapy that is going through trials today may become the new standard of care tomorrow. […] Along with treating your illness, a group of world-class professionals is here to support you. This team includes nurses, registered dietitians, physical therapists, social workers and psychologists. We also include supportive care services for your physical, mental and emotional well-being. […] When your care team makes your treatment plan, they will give you the choice to join clinical trials that match your situation. If you decide to join one, you will see the same physicians and nurses as you would for standard therapy. […] Your care team will talk with you about if you might want to join a study and why. This can help you make the decision that is best for you.

• #1 Current challenges and unmet medical needs in myelodysplastic syndromes | Leukemia

  https://www.nature.com/articles/s41375-021-01265-7

  Myelodysplastic syndromes (MDS) represent a heterogeneous group of myeloid neoplasms that are characterized by ineffective hematopoiesis, variable cytopenias, and a risk of progression to acute myeloid leukemia. Most patients with MDS are affected by anemia and anemia-related symptoms, which negatively impact their quality of life. […] While many patients with MDS have lower-risk disease and are managed by existing treatments or a watch-and-wait strategy, there is no standard of care for the majority of these patients; many are not candidates for approved treatments or experience relapse after first-line treatment and require further therapy. Thus, there remain many challenges and unmet needs for patients with MDS. This review will discuss some of the challenges related to the current MDS treatment landscape, as well as new approaches in development for the treatment of MDS.

• #1 Myelodysplastic Syndromes (MDS): Causes, Symptoms, Treatment

  https://www.webmd.com/cancer/lymphoma/myelodysplastic-syndrome-causes-symptoms-treatment

  Supportive care for MDS includes: […] Antibiotics for infections […] Erythropoiesis-stimulating agents. These medications increase the number of red blood cells in the body and minimize anemia effects. […] Blood transfusions. Blood transfusions work by replacing damaged blood cells with red blood cells or white blood cells. […] Platelet transfusion. This is a treatment option for people who may have a procedure that could cause bleeding […] Iron chelation. This type of treatment is recommended if you get too much iron in your blood from having many blood transfusions or are having a stem cell transplant (too much iron can affect the success of the transplant) […] Chemotherapy drugs. In people with low-risk forms of MDS, these types of drugs (like azacitidine [Vidaza] and decitabine [Dacogen]) might be a first choice.

• #1 Myelodysplastic Syndromes

  https://www.ajmc.com/compendium/myelodysplastic-syndromes

  Infection was a leading cause of death in lower-risk myelodysplastic syndromes (MDS), highlighting the need for vigilant monitoring and preventive strategies. […] ESA Treatment Improves OS in Lower-Risk MDS. […] Orca-T Immunotherapy Improves cGVHD-Free Survival in ALL, AML, MDS. […] Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients. […] Treosulfan in combination with fludarabine as preparation for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in adult and pediatric patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). […] Two abstracts presented at the 2024 American Society of Hematology Annual Meeting Exhibition provided insight into MDS response to hypomethylating agents (HMAs).

• #1 A Case Report on Myelodysplastic Syndrome with the Dysplasia of Two Cell Lineage – ASCLS

  https://ascls.org/a-case-report-on-myelodysplastic-syndrome/

  The management of MDS encompasses supportive care, disease modifying therapies, and in some cases stem cell transplantation. […] Treatment decisions in elderly patients need to consider their overall health and ability to tolerate therapies. […] Options may include supportive care (blood transfusions, growth factors), hypomethylating agents, or, in some cases, stem cell transplantation. […] The balance between managing the disease and maintaining comfort is crucial, especially in elderly individuals. […] Regular monitoring of blood counts and disease progression is essential. […] Considering the emotional and psychological aspects of the diagnosis is vital. […] Its important for the healthcare team, including hematologists and geriatric specialists, to work collaboratively to provide holistic care tailored to the individual needs and circumstances of the 88-year-old woman with MDS.

• #1 Myelodysplastic Syndrome (MDS) | Leukemia | UT Southwestern Medical Center

  https://utswmed.org/conditions-treatments/leukemia/myelodysplastic-syndrome-mds/

  The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern offers the most advanced treatments available for patients with MDS, MDS/MPN, and CMML. It is nationally recognized by the MDS Foundation as a center of excellence for the treatment of people with MDS. Our specialists are renowned for providing state-of-the-art care and advancing research related to cancer and blood diseases. […] Treatment for MDS, MDS/MPN, or CMML depends on the severity and symptoms of the disease. Our recommended approach might include: […] At UT Southwestern, we have expertise in using the most advanced treatments for MDS, overlap disorders, or CMML, including: […] Our care teams offer nutritional, spiritual, and transitional guidance from the start of a patients journey, through treatment, and beyond. The overall physical and emotional well-being of our patients is vital to achieving a positive outcome.

• #1 Self-Care Tips for Myelodysplastic Syndromes (MDS)

  https://www.healthline.com/health/mds-self-care

  MDS are cancerous bone marrow disorders that can cause symptoms such as weakness, frequent infections, and easy bruising. […] Myelodysplastic syndromes (MDS) are cancers that affect how your bone marrow creates new blood cells. […] Living with MDS can be physically and mentally challenging. Focusing on your well-being through self-care can help you manage symptoms, navigate the trials of treatment, and find balance in everyday life with MDS. […] Self-care for MDS involves eating a well-balanced diet, getting mental health support, and reducing your risk of infection, but other general practices of self-care such as quality sleep, exercise, and limiting alcohol are also important.

• #1 Myelodysplastic Syndromes (MDS) – Leukemia / Bone Marrow Transplant Program

  https://www.leukemiabmtprogram.org/patients-support-givers/diseases-treatments/myelodysplastic-syndromes-mds/

  Patients with MDS are only enrolled in the Leukemia, Blood and Marrow Transplant Program if they require specific treatments, including stem cell transplantation. […] If an individual is a candidate for a transplant, patients with MDS receive an allogeneic stem cell transplant. […] The transplant itself is a non-invasive procedure. The stem cells will be infused into the patient through an IV line that goes into their bloodstream. A nurse will be administering the stem cell transplant and they will remain with the patient the whole time. […] Your healthcare team will work closely with you to minimise any discomfort that you may have as a result of your treatment. […] Tell your healthcare team if you are experiencing pain. They can suggest comfort measures and sometimes pain medications that can help your body relax and rest. […] Talk openly about your feelings with your partner. […] It is safe to have intercourse once your blood cell counts have recovered. […] Your healthcare team can suggest a treatment specific to your symptoms. […] The LTFU Program can offer you support, treatment and education post-transplant.

• #1 Myelodysplastic Syndromes (MDS): Scoring and Treatment | OncoLink

  https://www.oncolink.org/cancers/blood-cancers/myelodysplastic-syndromes-mds/myelodysplastic-syndromes-mds-scoring-and-treatment

  Lenalidomide (Revlimid) often works well for low-grade or intermediate-risk MDS. It can stop the need for blood transfusions for some time. […] Thymoglobulin (Antithymocyte globulin [rabbit]) also called ATG is a type of immunosuppressant that can help treat subtypes of MDS in people under the age of 60. […] Chemotherapy is a group of medications used to treat the disease throughout the body. […] Allogeneic stem cell transplants (where the bone marrow comes from a donor) can be used to treat MDS. This is the only potential cure for people with MDS and is mostly used for people who are in good health, younger than 60, and who have a matched donor. […] You may be offered a clinical trial as part of your treatment plan. […] Your care team will make sure you are included in choosing your treatment plan. This can be overwhelming as you may be given a few options to choose from.

• #2 Myelodysplastic Syndrome (MDS): Practice Essentials, Pathophysiology, Etiology

  https://emedicine.medscape.com/article/207347-overview

  Myelodysplastic syndrome (MDS) refers to a heterogeneous group of closely related clonal hematopoietic disorders commonly found in the aging population. All are characterized by one or more peripheral blood cytopenias. Bone marrow is usually hypercellular, but rarely, a hypocellular marrow mimicking aplastic anemia may be seen. Bone marrow cells display aberrant morphology and maturation (dysmyelopoiesis), resulting in ineffective blood cell production. […] Standard care for MDS is constantly changing, but it typically includes supportive therapy, including transfusions, and may include bone marrow stimulation and cytotoxic chemotherapy or hypomethylating agents. Bone marrow transplantation has a limited role. (See Treatment.) […] Patients with MDS may present with clinical manifestations of anemia, thrombocytopenia, and/or neutropenia (see Presentation). The workup in patients with possible MDS includes a complete blood count with differential, peripheral blood smear, and bone marrow studies (see Workup).

• #2 Myelodysplastic syndrome (MDS): Symptoms, causes, and treatments

  https://www.medicalnewstoday.com/articles/319409

  Myelodysplastic syndrome (MDS) refers to a group of blood and bone marrow cancers. It develops when a person has low levels of certain types of blood cell in their body. […] Healthcare professionals used to call MDS preleukemia, or smoldering leukemia. However, as MDS only progresses to leukemia in around one-third of people, they now view it as being separate from leukemia. […] The early stages of MDS may have no apparent symptoms. Later symptoms depend on which type of blood cell has experienced damage or is in short supply. […] A blood test may reveal a reduced number of cells in the body. If the blood cell count for any one type is particularly low, a person may begin to experience some or all of the following symptoms. […] Having a lower amount of healthy red blood cells causes anemia. The signs of anemia often relate to a lack of oxygen reaching organs and cells around the body.

• #2 Patient education: Myelodysplastic syndromes (MDS) in adults (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/myelodysplastic-syndromes-mds-in-adults-beyond-the-basics

  Supportive care treats MDS-related problems such as infection or anemia as they arise, rather than trying to cure the underlying disease. Supportive care can improve quality of life and may prolong survival for all people with MDS. […] Transfusion of red blood cells or platelets can be given to relieve symptoms or when these blood counts become dangerously low. […] Hematopoietic growth factors promote the growth and development of blood cells and may reduce the need for blood transfusions. […] Low-intensity chemotherapy — Certain classes of drugs, or low doses of drugs from other classes, may be suggested for people with lower-risk MDS, or for people with higher-risk MDS who cannot tolerate high-intensity treatments. […] High-intensity chemotherapy — People with higher-risk MDS may be treated with low-intensity chemotherapy drugs azacitidine, decitabine, or decitabine/cedazuridine, or with chemotherapy similar to that used for treating acute myeloid leukemia (AML).

• #2 Myelodysplastic Syndromes (MDS): Causes, Symptoms, Treatment

  https://www.webmd.com/cancer/lymphoma/myelodysplastic-syndrome-causes-symptoms-treatment

  Supportive care for MDS includes: […] Antibiotics for infections […] Erythropoiesis-stimulating agents. These medications increase the number of red blood cells in the body and minimize anemia effects. […] Blood transfusions. Blood transfusions work by replacing damaged blood cells with red blood cells or white blood cells. […] Platelet transfusion. This is a treatment option for people who may have a procedure that could cause bleeding […] Iron chelation. This type of treatment is recommended if you get too much iron in your blood from having many blood transfusions or are having a stem cell transplant (too much iron can affect the success of the transplant) […] Chemotherapy drugs. In people with low-risk forms of MDS, these types of drugs (like azacitidine [Vidaza] and decitabine [Dacogen]) might be a first choice.

• #2 Myelodysplastic Syndromes (MDS): Causes, Symptoms, Treatment

  https://www.webmd.com/cancer/lymphoma/myelodysplastic-syndrome-causes-symptoms-treatment

  Here are some things to improve your health and well-being while living with MDS: […] To reduce your risk of infection, wash your hands frequently, cook your food well, avoid eating raw foods, and avoid being in close contact with people who are ill. […] Quit smoking or tobacco. […] Be as active as possible, eat healthy foods, and take your sleep seriously. […] Find and join a support group to meet with and learn from others who can relate to your experience with MDS. […] To relax your body and clear your mind, practice mindfulness and meditation practices like deep breathing, yoga, and journaling. […] Get professional mental health help from a therapist or counselor if living with MDS feels too overwhelming.

• #2 Patient education: Myelodysplastic syndromes (MDS) in adults (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/myelodysplastic-syndromes-mds-in-adults-beyond-the-basics/print

  Transfusion of red blood cells or platelets can be given to relieve symptoms or when these blood counts become dangerously low. […] Hematopoietic growth factors promote the growth and development of blood cells and may reduce the need for blood transfusions. However, many people with MDS do not respond adequately to hematopoietic growth factors because of the bone marrow’s defective production of blood cells, and the use of growth factors typically does not prolong survival. […] Vaccines help prevent infections and are especially important for people with MDS who have an increased risk of infections. However, not all vaccines are safe and appropriate for people with MDS, and they may not be as effective in people with MDS. […] High-intensity chemotherapy is not generally recommended for people >75 years old or for people with poor medical fitness or overall function. For these people, the expected benefit (prolonged survival) may not be worth the anticipated discomfort, hospitalization, or risk of death from the effects of chemotherapy. […] Stem cell transplantation is the treatment for MDS most associated with long-term survival, although long-term survivors can have complications such as „graft-versus-host disease” (GVHD). […] There is great interest in clinical trials for improving treatment of MDS. […] false

• #2 Current challenges and unmet medical needs in myelodysplastic syndromes | Leukemia

  https://www.nature.com/articles/s41375-021-01265-7

  Neutropenia remains an unmet medical need for many patients with MDS and can be associated with recurrent and/or serious infection. In low-risk MDS, granulocyte colony-stimulating factor is recommended for patients with life-threatening infections. In high-risk MDS, agents with the ability to change the natural course of the disease (i.e., HMAs) should be preferred.

• #2 If You Have Myelodysplastic Syndrome (MDS) | American Cancer Society

  https://www.cancer.org/cancer/types/myelodysplastic-syndrome/if-you-have-myelodysplastic-syndrome.html

  The treatment plan that is best for you will depend on the type of MDS you have, which risk group it falls into, your age and general health, if the MDS is causing symptoms, and other factors. […] For many people with MDS, one of the main goals of treatment is to prevent problems from low blood cell counts. Chemo and other treatments can often help with this, but sometimes you may need blood transfusions or other drugs to help manage your symptoms. […] A stem cell transplant (SCT), also known as a bone marrow transplant (BMT), offers the best chance to cure MDS, if it can be done. SCT lets doctors use very high doses of chemo to kill cells in the bone marrow. […] If you have MDS, you may go through a series of treatments with rests in between. Sometimes you may stop treatment for a while and have supportive care that treats other problems you have. […] You can’t change the fact that you have cancer. What you can change is how you live the rest of your life making healthy choices and feeling as good as you can.

• #2 Patient education: Myelodysplastic syndromes (MDS) in adults (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/myelodysplastic-syndromes-mds-in-adults-beyond-the-basics/print

  Several treatments for MDS can control symptoms, reduce or eliminate the need for blood or platelet transfusions, reduce the risk of complications, and improve the quality of life, and may prolong survival. Treatment choices are influenced by age, overall ability to perform daily tasks, and disease characteristics. […] Supportive care is an important part of the management of all people with MDS. This includes transfusions for low blood cell counts, antibiotics for infection, and certain immunizations. […] People with lower-risk MDS are generally treated with low-intensity therapy or supportive care alone. […] Treatment of people with higher-risk MDS may vary according to age, overall health, and personal preference. […] Supportive care treats MDS-related problems such as infection or anemia as they arise, rather than trying to cure the underlying disease. Supportive care can improve quality of life and may prolong survival for all people with MDS.

• #2 Myelodysplastic Syndromes (MDS) Care | UC San Diego Health

  https://health.ucsd.edu/care/cancer/cancers-we-treat/leukemia-lymphoma/mds/

  Our physician-researchers identified gene mutations that can help establish a diagnosis, predict response to treatment, and affect the survival of patients with MDS. […] Depending on whether you have a low-risk or high-risk form of MDS, your care plan may include one or more of the following: […] Active observation without therapy […] Blood transfusions […] Growth factor therapy to increase red blood cell production (usually erythropoietin or granulocyte colony-stimulating factor) […] Lenalidomide (Revlimid) for those with chromosome 5q deletion […] Immune suppression for individuals with features of aplastic anemia […] Supportive drug therapy, which may include antibiotics to fight infections or medications to help reduce the need for transfusions […] Azacitidine (Vidaza), or decitabine (Dacogen) for high-risk disease

• #2 Myelodysplastic syndrome – Wikipedia

  https://en.wikipedia.org/wiki/Myelodysplastic_syndrome

  For those with high risk MDS (characterized by an IPSS score greater than 3.5), the hypomethylating agent azacitidine showed increased survival compared to standard care (supportive care, cytarabine or chemotherapy) and is considered the standard of care. Azacitidine had increased survival (24 months vs 15 months) and higher rates of partial or complete therapeutic response (29% vs 12%) as compared to conventional care.

• #2 Myelodysplastic Syndromes (MDS) | UH Seidman Cancer Center | University Hospitals | University Hospitals

  https://www.uhhospitals.org/services/cancer-services/hematologic-malignancy/leukemia/myelodysplastic-syndromes

  Medication therapy for myelodysplastic syndromes may include some combination of the following: […] A bone marrow transplant, also known as a stem cell transplant, is the only treatment option that can potentially cure MDSs. […] Because a bone marrow transplant carries a high risk of complications, this procedure is reserved for patients deemed healthy enough to endure it. […] Some people with a MDS live for years and require little or no treatment. […] For others, their MDS is more aggressive and may develop into acute myeloid leukemia (AML), which is an aggressive, life-threatening cancer that requires more urgent treatment.

• #2 Myelodysplastic syndromes: update and nursing considerations – World Continuing Education Alliance

  https://wcealms.com/product/myelodysplastic-syndromes-update-and-nursing-considerations/

  This module provides nurses with an update on diagnosis, management and care of patients with myelodysplastic syndromes (MDS), a complex group of disorders of the bone marrow. […] Understanding the effect of a diagnosis of MDS on patients quality of life is an important part of the nursing role and includes consideration of physical, mental, emotional and social wellbeing. […] Many treatment options are available and nurses can educate patients on recognising and managing side effects. […] While there have been promising developments in management, nurses should ensure that patients and their families have a realistic understanding of MDS and ensure that they are aware that treatments other than haematopoietic stem cell transplantation are non-curative.

• #2 Patient and Family Resources for Living With Myelodysplastic Syndromes | Oncology Nursing Society

  http://www.ons.org/patient-and-family-resources-living-myelodysplastic-syndromes

  Primarily a disease affecting older adults, myelodysplastic syndromes (MDS) are a class of incurable myeloid malignancies with variable clinical presentation, treatment recommendations, and prognoses. […] Although effective communication between healthcare professionals and patients and their caregivers is a significant part of optimizing clinical outcomes, studies have shown that all three frequently have an incomplete understanding of MDS, its therapeutic options, and the fact that MDS is a malignancy. […] In addition, the advanced age of the patient population, high frequency of comorbidities, and variability of disease outcomes based on risk status require consistent communication across a wide number and type of healthcare providers as well as an individualized approach to patient and caregiver education. […] This article discusses these challenges and provides a number of resources designed to help educate healthcare professionals, patients, and caregivers.

• #2 Case Presentation: Myelodysplastic Syndromes

  https://www.oncnursingnews.com/view/case-presentation-myelodysplastic-syndromes

  There are several treatment choices available for patients diagnosed with MDS. […] The treatments include growth factors such as Procrit (epoetin alfa) and Neupogen (filgrastim). […] Hypomethylating agents, such as 5-azacytidine and decitabine, are often used as low-intensity therapies. […] Lenalidomide (Revlimid) is FDA-approved for patients with MDS containing a 5q- abnormality. […] It is important as a nurse practitioner to review the side effects with both the patient and caregivers if present at each office visit. […] Side effects related to taking lenalidomide include thrombocytopenia, serious birth defects, neutropenia, blood clots, skin reactions including rashes, and tumor lysis syndrome. […] The patient was prescribed 10 mg of lenalidomide daily. […] The patient came to the office weekly for 8 weeks, experiencing only thrombocytopenia, which eventually resolved, with the remaining blood counts showing normal levels.

• #2 Myelodysplastic Syndromes (MDS) Care | Rush

  https://www.rush.edu/services/myelodysplastic-syndromes-mds-care

  Rush has myelodysplastic syndromes (MDS) myeloproliferative neoplasms providers in Chicago and Lisle. […] You may receive care through the MDS Comprehensive Clinic at Rush, where a team of specialists including hematologists, pathologists, bone marrow transplantation specialists and research staff gathers to review your condition and create a treatment plan that meets your needs. […] At Rush, your care goes beyond medications and procedures. Youll also have access to supportive oncology services, which can include nutrition counseling, complementary therapies (e.g., acupuncture, massage), palliative care to help manage symptoms and side effects, psychosocial oncology, financial counseling, transportation assistance and more. […] Waterford Place at Rush Copley Medical Center offers you and your loved ones support before, during and after a cancer diagnosis, with all services free of charge or available to anyone diagnosed with cancer. Waterford Place offers education, support groups, stress reduction programs, nutritional counseling, yoga and a salon and spa that provides massages and facials, as well as the largest wig boutique in the Aurora/Fox Valley area. […] Researchers at Rush are investigating new blood disorders and hematologic cancer treatments.

• #2 Myelodysplastic Syndromes (MDS) | Dana-Farber Cancer Institute

  https://www.dana-farber.org/cancer-care/types/myelodysplastic-syndromes

  We provide comprehensive services to patients with these cancers, including: A highly specialized program focusing on MDS diagnostics, treatment, and research, Consultations and second opinions for patients and physicians nationally and internationally, Access to the latest diagnostics, such as molecular and genomic profiling, including the Rapid Heme Panel, which was developed by our scientists to rapidly detect key mutations that are important for developing timely treatment plans, Collaboration with our internationally recognized bone marrow/stem cell transplantation program, Care plans tailored to the needs of each patient, from the first meeting through long-term monitoring, Access to new therapies through clinical trials, Access to support programs such as nutrition services, social work support, integrative therapies, and survivorship programs, Multidisciplinary care delivered by specialists from Dana-Farber Cancer Institute and Brigham and Womens Hospital.

• #2 How Can Palliative Care Help MDS Patients? – HealthTree for Myelodysplastic Syndromes

  https://healthtree.org/mds/community/articles/asco-24-how-can-palliative-care-help-mds-patients

  Dr. Areej El-Jawahri from Massachusetts General Hospital shared findings at the ASCO 2024 conference in June about how palliative care can improve high-risk MDS patients quality of life and better prepare them for potential end-of-life care plans. […] High-risk MDS patients who receive non-intensive chemotherapy often report low quality of life and dont discuss their end-of-life care preferences with their doctor. […] In conclusion, adding a palliative care professional to the healthcare team of high-risk MDS patients on non-intensive chemotherapy improved their quality of life and ability to have timely discussions about end-of-life care preferences. […] We invite you to consider adding a palliative care provider to your healthcare team as soon as possible to gain these benefits.

• #2 Centers of Excellence | MDS Foundation

  https://www.mds-foundation.org/community/centers-of-excellence

  We believe that access to top-tier care is crucial for individuals living with MDS. That’s why we’ve curated a list of Centers of Excellence dedicated to providing exceptional care and support for MDS patients. […] Centers of Excellence are institutions recognized for their expertise, innovative treatments, and commitment to improving outcomes for MDS patients. […] Provide a second opinion by an MDS expert physician who is up to date on the latest treatments. […] Equip you with the most updated diagnostic tools. […] Explore our network of Centers of Excellence to discover top-tier institutions dedicated to MDS care and research.

• #2 Myelodysplastic Syndrome (MDS) Treatment & Management: Approach Considerations, Supportive Care, Pharmacologic Therapy

  https://emedicine.medscape.com/article/207347-treatment

  Supportive care includes transfusion of red blood cells (RBCs) or platelets. The goal is to replace cells that are prematurely undergoing apoptosis in the patient’s bone marrow. […] Patients with low-risk or intermediate-1 risk MDS typically have long-term survival and may receive multiple RBC transfusions. These patients may develop transfusion-induced iron overload and can incur significant damage of the liver, heart, pancreas, and other tissues. […] Current guidelines recommend starting iron chelation therapy in those patients who have received 20-25 units of packed RBCs or who have a serum ferritin level of 1000 g/L. […] Hematopoietic growth factors can stimulate bone marrow cell production and decrease excess bone marrow cell apoptosis. […] Cytotoxic chemotherapy is used in patients with MDS with increasing myeloblasts and those who have progressed to acute leukemia.

• #2 Myelodysplastic Syndromes – What You Need to Know

  https://www.drugs.com/cg/myelodysplastic-syndromes.html

  MDS are a group of conditions that prevent stem cells in your bone marrow from working properly. […] Medicines may help stop the growth of faulty stem cells. They may help prevent normal stem cells from becoming defective. Other medicine will increase the number of RBCs, WBCs, or platelets. You may also need medicine to stop your immune system from attacking your stem cells, RBCs, WBCs, or platelets. Medicine may be given to prevent or treat an infection. […] It is important to lower your risk for bleeding, bruising, and infections: […] Ask about vaccines you may need. Vaccines help protect you from some bacterial and viral infections. Your healthcare provider may recommend these and other vaccines: […] You have the right to help plan your care. Learn about your health condition and how it may be treated. Discuss treatment options with your healthcare providers to decide what care you want to receive. You always have the right to refuse treatment.

• #2 Myelodysplastic Syndrome Types and Treatments | UPMC

  https://hillman.upmc.com/cancer-care/blood/types/mds

  Your doctor may suggest: Chemo for people with lower-risk MDS to help control it. Chemo may be too toxic for people who are elderly or have other health problems. […] Blood cell growth factors. Hormone-like substances that help bone marrow make new blood cells. […] Red blood cell transfusions to combat anemia. […] Antibiotics to treat suspected bacterial infections. […] Platelet transfusions to treat bleeding or bruising from a shortage of platelets. […] Chelating agents to help the body get rid of excess iron from blood transfusions. […] If one treatment doesn’t work, your doctor may try another. […] They may also suggest you take part in a clinical trial of new MDS drugs and treatments. […] Prognosis depends on the type of syndrome and how well you respond to treatment. […] Our experts and care team are among the most qualified in the world for treating MDS and other types of blood cancers. […] We use the latest technology and techniques in diagnosing and treating MDS. […] We offer blood cancer clinical trials that provide access to new treatments you might not find elsewhere.

• #2 Nursing Education Modules on MDS Disease Management and Patient Education | Aplastic Anemia and MDS International Foundation (AAMDSIF)

  https://www.aamds.org/nursing-education-modules-mds-disease-management-and-patient-education

  This program reviews the role of the nurse in educating patients and caregivers about myelodysplastic syndromes (MDS), including: […] Nursing interventions that may improve QOL for MDS patients. […] This program reviews the ways nurses can help patients adjust to living well with myelodysplastic syndromes (MDS), including: […] Strategies to help MDS patients with physical and mental aspects of disease.

• #2 Nursing Education Modules on MDS Disease Management and Patient Education | Aplastic Anemia and MDS International Foundation (AAMDSIF)

  https://www.aamds.org/nursing-education-modules-mds-disease-management-and-patient-education

  Innovations in the diagnosis, risk stratification, and treatment of myelodysplastic syndromes (MDS) provide hope for patients while creating challenges for their health care providers. Nurses play an integral role in providing patients with clear explanations, setting treatment expectations, and empowering them to be actively in their care decisions. […] The AA&MDSIF Nursing Modules have been designed to provide a convenient, comprehensive summary of MDS disease basics, treatment options, quality of life issues, and patient education and support. […] This program reviews the treatment options for myelodysplastic syndromes (MDS) and the goals of therapy for MDS patients, including: […] MDS treatment goals – individualized therapy, minimal toxicity, improvement of blood counts, transfusion independence, delay of leukemic transformation, improved survival, quality of life.

• #2 A Primary Care Approach to Myelodysplastic Syndromes

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4040428/

  PCPs, especially those who have established, long-term professional relationships with their patients, can also assist with counseling. […] Becoming familiar with the basic principles of MDS diagnosis and management can help PCPs ensure earlier diagnosis and better care for patients affected by MDS, improving patients’ quality and longevity of life particularly when there are increasing numbers of MDS patients. […] In the face of limited resources PCPs can have an important role in improving access, coordinating cancer care and optimizing quality of care in patients with MDS.

Zobacz więcej